Publications

Journal Article
Research Support, Non-U.S. Gov't
Ppublish 193 citations
Electronic publication date
February 10, 2011

View on Pubmed.gov 21036908 | View on doi.org 10.1074/jbc.M11...

MicroRNA-155 targets SMAD2 and modulates the response of macrophages to transforming growth factor-{beta}.

Search for publications in this journal J Biol Chem - 285(53):41328-36

Abstract

Transforming growth factor-beta (TGF-β) is a pleiotropic cytokine with important effects on processes such as fibrosis, angiogenesis, and immunosupression. Using bioinformatics, we identified SMAD2, one of the mediators of TGF-β signaling, as a predicted target for a microRNA, microRNA-155 (miR-155). MicroRNAs are a class of small non-coding RNAs that have emerged as an important class of gene expression regulators. miR-155 has been found to be involved in the regulation of the immune response in myeloid cells. Here, we provide direct evidence of binding of miR-155 to a predicted binding site and the ability of miR-155 to repress SMAD2 protein expression. We employed a lentivirally transduced monocyte cell line (THP1-155) containing an inducible miR-155 transgene to show that endogenous levels of SMAD2 protein were decreased after sustained overexpression of miR-155. This decrease in SMAD2 led to a reduction in both TGF-β-induced SMAD-2 phosphorylation and SMAD-2-dependent activation of the expression of the CAGA(12)LUC reporter plasmid. Overexpression of miR-155 altered the cellular responses to TGF-β by changing the expression of a set of genes that is involved in inflammation, fibrosis, and angiogenesis. Our study provides firm evidence of a role for miR-155 in directly repressing SMAD2 expression, and our results demonstrate the relevance of one of the two predicted target sites in SMAD2 3'-UTR. Altogether, our data uncover an important role for miR-155 in modulating the cellular response to TGF-β with possible implications in several human diseases where homeostasis of TGF-β might be altered.

References

EMBO J. 2000 Apr 17;19(8):1745-54

Proc Natl Acad Sci U S A. 2007 Jan 30;104(5):1604-9

J Clin Invest. 2001 Aug;108(4):601-9

Nat Med. 2001 Oct;7(10):1118-22

Cited by 193 citations (total)

Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer.

Electronic publication date July 10, 2013

Search for publications in this journal Immunity

Jan C Dudda [...] Pedro Romero et al.

MicroRNAs (miRNAs) regulate the function of several immune cells, but their role in promoting CD8(+) T cell immunity remains unknown. Here...

Journal Article

MicroRNAs: New players in cancer prevention targeting Nrf2, oxidative stress and inflammatory pathways.

Electronic publication date December 1, 2015

Search for publications in this journal Curr Pharmacol Rep

Chengyue Zhang [...] Ah-Ng Tony Kong et al.

miRNAs are endogenous small non-coding RNAs of 20-22 nucleotides that repress gene expression at the post-transcriptional level. There is growing...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances